I want to thank the honourable member for that question. Being accessible and transparent and having the opportunity to speak directly to Canadians through this committee is absolutely important.
I very much appreciate the invitation that I received on this very important issue. I know how urgent this matter is for Canadians, and we are seized with it, which is why you heard me talk about how we are on top of it and we intend to stay on top of it, and how serious it is for me and for my colleagues and the Prime Minister to ensure that there is no disruption in the shipment of vaccines to Canada. Those are the reassurances that I have received directly from the executive vice-president, from Trade Commissioner Dombrovskis in the EU, but Minister of Health Hajdu has also received similar assurances from the commissioner of health in the EU, and the Prime Minister has as well, from the EU president.
The honourable member also talked about the number of vaccines and what we expect. We are expecting to be on track to receive the six million doses of vaccines from both Pfizer and Moderna. We expect that we will be able to vaccinate three million Canadians by the end of Q1 just with those vaccines that are approved right now.
As my colleagues have shared publicly before, Canada has procured a robust portfolio of vaccines for Canadians, and absolutely, we all agree—the EU and Canada—that COVID-19 has no borders and that we all need to work together to fight COVID-19 and to make sure that people around the world also have access to vaccines.
We're going to continue to work on this. We must continue to work on this. I want to assure you that it is absolutely my top priority to stay on top of this and to work on ensuring that the vaccines we get from the European Union are not disrupted through this mechanism and make their way here to Canada for Canadians.